6-Methyl-2,6-diazaspiro[3.4]octan-7-one hydrochloride

Catalog No.: 
ACJCSL185
CAS No.: 
2097951-61-4
Molecular Formula: 
C7H13ClN2O
Molecular Weight: 
176.65
6-Methyl-2,6-diazaspiro[3.4]octan-7-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$101.00In stockInquiry
250mg97%$202.00In stockInquiry
1g97%$505.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Methyl-2,6-diazaspiro[3.4]octan-7-one hydrochloride
IUPAC Name6-methyl-2,6-diazaspiro[3.4]octan-7-one hydrochloride
MDL No.MFCD30494941
Molecular FormulaC7H13ClN2O
Molecular Weight176.65
SMILESO=C(C1)N(C)CC21CNC2.[H]Cl
InChI KeyHRENNFLBJMIXPU-UHFFFAOYSA-N
Synonym2097951-61-4 | 6-methyl-2,6-diazaspiro[3.4]octan-7-one hydrochloride | 6-methyl-2,6-diazaspiro[3.4]octan-7-one | hydrochloride | MFCD30494941 | AKOS040818479 | E73685 | 6-methyl-2,6-diazaspiro[3.4]octan-7-onehydrochloride | F2167-8367
CAS No.2097951-61-4
PubChem CID126847366

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJCSL185 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJCSL185 route product structure diagram
    ACJCSL1852097951-61-4In Stock
Inquiry

2. ACJCSL185 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJCSL185 route product structure diagram
    ACJCSL1852097951-61-4In Stock
Inquiry

3. ACJCSL185 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJCSL185 route product structure diagram
    ACJCSL1852097951-61-4In Stock
Inquiry

Comments (0)